NewsNTech
Laboratory testing shapes nearly 70% of clinical decisions, a figure that positions it as the single highest-influence input in routine care.
When the dollars spent on that category grow faster than actual test volume, it is a management signal, not a demand story.
Avalon's 2026 Lab Trend Report, issued July 21, 2026 from Tampa, places that gap at the center of its diagnostic management analysis. The spend-utilization divergence The mechanism behind the gap matters.
In a well-managed lab benefit, spend and utilization track each other: more decisions require more tests, and cost grows proportionately.
Keep reading